A facile and green synthesis of platinum nanoparticles [gum kondagogu platinum nanoparticles (GKPtNP)] using biopolymer-gum kondagogu was developed. The formation of GKPtNP was confirmed by ultraviolet (UV)-visible spectroscopy, scanning electron microscopy-energy dispersive X-ray spectroscopy, transmission electron microscopy, X-ray diffraction, Zeta potential, Fourier transform infrared, inductively coupled plasma mass spectroscopy. The formed GKPtNP are well dispersed, homogeneous with a size of 2-4 ± 0.50 nm, having a negative zeta potential (−46.1 mV) indicating good stability. 5-Fluorouracil (5FU) was loaded onto the synthesised GKPtNP, which leads to the development of a new combination of nanomedicine (5FU-GKPtNP). The in vitro drug release studies of 5FU-GKPtNP in pH 7.4 showed a sustained release profile over a period of 120 min. Agrobacterium tumefaciens induced in vitro potato tumour bioassay was employed for screening the anti-tumour potentials of GKPtNP, 5FU, and 5FU-GKPtNP. The experimental results suggested a complete tumour inhibition by 5FU-GKPtNP at a lower concentration than the GKPtNP and 5FU. Furthermore, the mechanism of anti-tumour activity was assessed by their interactions with DNA using agarose gel electrophoresis and UV-spectroscopic analysis. The electrophoresis results revealed that the 5FU-GKPtNP totally diminishes DNA and the UV-spectroscopic analysis showed a hyperchromic effect with red shift indicating intercalation type of binding with DNA. Over all, the present study revealed that the combined exposure of the nanoformulation resulted in the enhanced anti-tumour effect.